LifePoint Health (LPNT) Tops Q4 EPS by 10c; Issues Mixed FY16 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Mizuho Securities Cuts Price target on LifePoint Health (LPNT) Following 2016 EPS Dilution
February 16, 2016 7:00 AM ESTMizuho Securities reiterated a Neutral rating on LifePoint Health (NASDAQ: LPNT), and cut the price target to $59.40 (from $74.00), resulting from the dilution to 2016 EPS and the sharp drop in FCF as a result of its acquisition strategy. Mizuho believes that LPNT is still... More
